JP2012522814A5 - - Google Patents

Download PDF

Info

Publication number
JP2012522814A5
JP2012522814A5 JP2012503892A JP2012503892A JP2012522814A5 JP 2012522814 A5 JP2012522814 A5 JP 2012522814A5 JP 2012503892 A JP2012503892 A JP 2012503892A JP 2012503892 A JP2012503892 A JP 2012503892A JP 2012522814 A5 JP2012522814 A5 JP 2012522814A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
substituted
fluorine
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012503892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012522814A (ja
JP5608217B2 (ja
Filing date
Publication date
Priority claimed from DE102009016553A external-priority patent/DE102009016553A1/de
Application filed filed Critical
Publication of JP2012522814A publication Critical patent/JP2012522814A/ja
Publication of JP2012522814A5 publication Critical patent/JP2012522814A5/ja
Application granted granted Critical
Publication of JP5608217B2 publication Critical patent/JP5608217B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012503892A 2009-04-06 2010-03-30 スルホン酸アミドおよびスルホキシイミン置換ジアリール−シヒドロピリミジノンおよびその使用 Expired - Fee Related JP5608217B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009016553A DE102009016553A1 (de) 2009-04-06 2009-04-06 Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung
DE102009016553.3 2009-04-06
PCT/EP2010/002000 WO2010115548A1 (de) 2009-04-06 2010-03-30 Sulfonamid- und sulfoximin-substituierte diaryldihydropyrimidinone und ihre verwendung

Publications (3)

Publication Number Publication Date
JP2012522814A JP2012522814A (ja) 2012-09-27
JP2012522814A5 true JP2012522814A5 (enExample) 2013-05-02
JP5608217B2 JP5608217B2 (ja) 2014-10-15

Family

ID=42138772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012503892A Expired - Fee Related JP5608217B2 (ja) 2009-04-06 2010-03-30 スルホン酸アミドおよびスルホキシイミン置換ジアリール−シヒドロピリミジノンおよびその使用

Country Status (8)

Country Link
US (1) US8691817B2 (enExample)
EP (1) EP2417112B1 (enExample)
JP (1) JP5608217B2 (enExample)
CN (1) CN102482231B (enExample)
CA (1) CA2757654C (enExample)
DE (1) DE102009016553A1 (enExample)
ES (1) ES2499417T3 (enExample)
WO (1) WO2010115548A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2234985T1 (sl) * 2007-12-20 2012-06-29 Bayer Pharma AG 4-(4-ciano-2-tioaril)dihidropirimidinoni in njihova uporaba
US20140221335A1 (en) 2013-02-06 2014-08-07 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9115093B2 (en) 2013-03-04 2015-08-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
USRE47493E1 (en) 2014-02-20 2019-07-09 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US20170114049A1 (en) 2014-04-03 2017-04-27 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases
EP3126339A1 (de) 2014-04-03 2017-02-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung
JP2017511319A (ja) 2014-04-03 2017-04-20 バイエル ファーマ アクチエンゲゼルシャフト キラル2,5−ジ置換されたシクロペンタンカルボン酸誘導体およびそれの使用
US9657015B2 (en) 2014-07-31 2017-05-23 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9458113B2 (en) 2014-07-31 2016-10-04 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9475779B2 (en) 2014-07-31 2016-10-25 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9440930B2 (en) 2014-07-31 2016-09-13 Boehringer Ingelheim International Gmbh Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US9290457B2 (en) * 2014-07-31 2016-03-22 Boehringer Ingelheim International Gmbh Substituted dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
US10316001B2 (en) 2015-03-18 2019-06-11 Ph Pharma Co., Ltd. Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile
US20190008867A1 (en) 2015-11-13 2019-01-10 Ph Pharma Co., Ltd. 4-(4-cyano-2-thioaryl)dihydropyrimidinones for treating chronic wounds
WO2024161371A1 (en) * 2023-02-02 2024-08-08 Gt Gain Therapeutics Sa Substituted azoles their use in the treatment of diseases associated with alpha-1 -antitrypsin (a1at) deficiency
CN118845775B (zh) * 2024-09-24 2024-12-20 四川大学华西第二医院 Iacs-010759在制备预防和/或治疗原发性纤毛不动综合征的药物中的用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834047A1 (de) 1998-07-29 2000-02-03 Bayer Ag Substituierte Pyrazolderivate
DE19834044A1 (de) 1998-07-29 2000-02-03 Bayer Ag Neue substituierte Pyrazolderivate
DE19943639A1 (de) 1999-09-13 2001-03-15 Bayer Ag Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften
DE19943635A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943636A1 (de) 1999-09-13 2001-03-15 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE19943634A1 (de) 1999-09-13 2001-04-12 Bayer Ag Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften
AR031176A1 (es) 2000-11-22 2003-09-10 Bayer Ag Nuevos derivados de pirazolpiridina sustituidos con piridina
DE10110750A1 (de) 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
DE10110749A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte Aminodicarbonsäurederivate
DE10220570A1 (de) 2002-05-08 2003-11-20 Bayer Ag Carbamat-substituierte Pyrazolopyridine
AU2003255492A1 (en) 2002-09-10 2004-04-30 Bayer Healthcare Ag Heterocyclic derivatives
MXPA05002644A (es) 2002-09-10 2005-09-20 Bayer Healthcare Ag Derivados de pirimidinona como agentes terapeuticos contra procesos de remodelacion, isquemicos e inflamatorios agudos y cronicos.
GB2392910A (en) * 2002-09-10 2004-03-17 Bayer Ag 2-Oxopyrimidine derivatives and their use as human leukocyte elastase inhibitors
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
EP1730121B1 (en) 2004-02-26 2013-08-07 Bayer Intellectual Property GmbH 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
JP4825194B2 (ja) 2004-02-26 2011-11-30 バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト 1,4−ジアリール−ジヒドロピリミジン−2−オン化合物およびヒト好中球エラスターゼ阻害剤としてのそれらの使用
JP2008508356A (ja) 2004-08-02 2008-03-21 スミスクライン ビーチャム コーポレーション Hpv感染に有用な化合物
GB0502258D0 (en) 2005-02-03 2005-03-09 Argenta Discovery Ltd Compounds and their use
GB0512940D0 (en) 2005-06-24 2005-08-03 Argenta Discovery Ltd Compounds and their use
GB0520743D0 (en) 2005-10-12 2005-11-23 Argenta Discovery Ltd Compounds and their use
US20100010024A1 (en) 2006-07-01 2010-01-14 Bayer Healthcare Ag Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension
DE102006031314A1 (de) 2006-07-01 2008-01-03 Bayer Healthcare Aktiengesellschaft Verwendung von 1,4-Diaryl-dihydropyrimidin-2-on-Derivaten zur Behandlung der pulmonalen arteriellen Hyptertonie
US20110003858A1 (en) 2006-09-04 2011-01-06 Bergstroem Lena Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
SI2234985T1 (sl) * 2007-12-20 2012-06-29 Bayer Pharma AG 4-(4-ciano-2-tioaril)dihidropirimidinoni in njihova uporaba

Similar Documents

Publication Publication Date Title
JP2012522814A5 (enExample)
CA2709786A1 (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
JP2015516000A5 (enExample)
JP2016535769A5 (enExample)
JP7649289B2 (ja) アルキニルキナゾリン化合物
CA2749040A1 (en) Triazolo and tetrazolo pyrimidine derivatives as hne inhibitors for treating copd
CA2723559A1 (en) 1,4-diaryl-pyrimidopyridazine-2,5-diones and their use
CA2562859A1 (en) Novel enantiomerically pure beta-agonists, method for the production and the use thereof in the form of a drug
JP2011506501A5 (enExample)
CA2726020A1 (en) 2-alkoxy-substituted dicyanopyridines and use thereof
JP2009515988A5 (enExample)
JP2006524225A5 (enExample)
JP2020517616A5 (enExample)
JP2005508967A5 (enExample)
JP2005537854A5 (enExample)
JP2007535551A5 (enExample)
JP2010510999A5 (enExample)
JP2011037841A5 (enExample)
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
JP2004525174A5 (enExample)
JP2016536362A5 (enExample)
JP2007502295A5 (enExample)
JP2005505618A5 (enExample)
JP2019522628A5 (enExample)
JP2015520738A5 (enExample)